Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia – A prospective family cohort study in asymptomatic subjects

Anja B. U. Mäkelburg; Willem M. Lijfering; Saskia Middeldorp; Karly Hamulyák; Nic J. G. M. Veeger; Martin H. Prins; Harry R. Büller; Jan van der Meer

doi:10.1160/TH08-04-0224

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2009; 101(01): 209-212
DOI: 10.1160/TH08-04-0224

Letters to the Editor

Schattauer GmbH

Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia – A prospective family cohort study in asymptomatic subjects

Authors

Anja B. U. Mäkelburg

¹Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
Willem M. Lijfering

¹Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
Saskia Middeldorp

²Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
Karly Hamulyák

³Department of Haematology, University Hospital Maastricht, Maastricht, The Netherlands
Nic J. G. M. Veeger

¹Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands
Martin H. Prins

⁴Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, Maastricht, The Netherlands.
Harry R. Büller

²Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands
Jan van der Meer

¹Division of Haemostasis, Thrombosis and Rheology, Department of Haematology, University Medical Centre Groningen, Groningen, The Netherlands

Abstract

Full Text

References

References
1 McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111-128.
2 The Homocysteine Studies Collaboration.. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002; 288: 2015-2022.
3 den Heijer M, Rosendaal FR, Blom HJ. et al. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874-877.
4 Bonaa KH, Njolstad I, Ueland PM. et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354: 1578-1588.
5 den Heijer M, Willems HP, Blom HJ. et al. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood 2007; 109: 139-144.
6 Lonn E, Yusuf S, Arnold MJ. et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567-1577.
7 Ray JG, Kearon C, Yi Q. et al. Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial. Ann Intern Med 2007; 146: 761-767.
8 Lijfering WM, Coppens M, van de Poel MH. et al. The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects. Thromb Haemost 2007; 98: 457-463.
9 den Heijer M, Koster T, Blom HJ. et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-762.
10 Lijfering WM, Veeger NJ, Brouwer JL. et al. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis. J Thromb Haemost 2007; 05: 614-616.
11 Keijzer MB, Verhoef P, Borm GF. et al. No added value of the methionine loading task in assessment for venous thrombosis and cardiovascular disease risk. Thromb Haemost 2006; 95: 380-385.
12 Martinelli I, Bucciarelli P, Zighetti ML. et al. Low risk of thrombosis in family members of patients with hyperhomocysteinaemia. Br J Haematol 2002; 117: 709-711.
13 Nordstrom M, Lindblad B, Bergqvist D. et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155-160.
14 Vasan RS, Benjamin EV, Sullivan LM. et al. The Burden of Increasing Worldwide Cardiovascular Disease. In: Fuster V, O’Rourke RA, Walsh RA, Poole-Wilson P. editors. Hurst’s The Heart. New York: McGraw-Hill; Medical Pub. Division 2007
15 Vaya A, Gomez I, Mira Y. et al. Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects. Thromb Haemost 2008; 99: 1132-1134.